Viridian Therapeutics, Inc. (VRDN)
29.04
+3.88
(+15.45%)
USD |
NASDAQ |
Nov 04, 16:00
29.33
+0.30
(+1.02%)
After-Hours: 19:30
Viridian Therapeutics Total Return Price : 29.04 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 25.15 |
| November 02, 2026 | 25.30 |
| October 30, 2026 | 24.67 |
| October 29, 2026 | 24.80 |
| October 28, 2026 | 24.27 |
| October 27, 2026 | 24.09 |
| October 26, 2026 | 23.34 |
| October 23, 2026 | 22.37 |
| October 22, 2026 | 22.82 |
| October 21, 2026 | 23.01 |
| October 20, 2026 | 22.43 |
| October 19, 2026 | 20.80 |
| October 16, 2026 | 19.03 |
| October 15, 2026 | 19.56 |
| October 14, 2026 | 18.38 |
| October 13, 2026 | 18.22 |
| October 12, 2026 | 18.30 |
| October 09, 2026 | 18.66 |
| October 08, 2026 | 18.34 |
| October 07, 2026 | 18.28 |
| October 06, 2026 | 18.22 |
| October 05, 2026 | 19.00 |
| October 02, 2026 | 19.40 |
| October 01, 2026 | 18.99 |
| September 30, 2026 | 20.59 |
| Date | Value |
|---|---|
| September 29, 2026 | 20.00 |
| September 28, 2026 | 20.57 |
| September 25, 2026 | 20.47 |
| September 24, 2026 | 20.66 |
| September 23, 2026 | 21.43 |
| September 22, 2026 | 22.12 |
| September 21, 2026 | 21.58 |
| September 18, 2026 | 22.00 |
| September 17, 2026 | 21.93 |
| September 16, 2026 | 22.44 |
| September 15, 2026 | 21.83 |
| September 14, 2026 | 22.20 |
| September 11, 2026 | 21.24 |
| September 10, 2026 | 22.29 |
| September 09, 2026 | 22.73 |
| September 08, 2026 | 23.17 |
| September 04, 2026 | 22.92 |
| September 03, 2026 | 22.96 |
| September 02, 2026 | 22.78 |
| September 01, 2026 | 23.03 |
| August 31, 2026 | 23.16 |
| August 28, 2026 | 23.08 |
| August 27, 2026 | 23.88 |
| August 26, 2026 | 24.26 |
| August 25, 2026 | 24.18 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 549.06 |
| TG Therapeutics, Inc. | 61.64 |
| Travere Therapeutics, Inc. | 52.42 |
| ACADIA Pharmaceuticals, Inc. | 21.50 |
| Alnylam Pharmaceuticals, Inc. | 160.91 |